• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US launch

cafead

Administrator
Staff member
  • cafead   Apr 12, 2023 at 11:32: AM
via The modification of an existing collaboration agreement with AstraZeneca gives Sanofi full commercial control of RSV antibody Beyfortus (nirsevimab) and 'enhanced agility' in the US market.

article source
 

<